Figure 1: Canadian Malartic Production Profile
Osisko Announces Preliminary Q3 2023 Deliveries, Along With Record Quarterly Revenues and Cash Margin and Provides Portfolio Updates
October 11, 2023 17:00 ET | Osisko Gold Royalties Ltd.
MONTRÉAL, Oct. 11, 2023 (GLOBE NEWSWIRE) -- Osisko Gold Royalties Ltd (the “Corporation” or “Osisko”) (OR: TSX & NYSE) is pleased to provide an update on its third quarter 2023 deliveries,...
SAB Biotherapeutics to Host Virtual 2022 Annual R&D Portfolio Update
August 04, 2022 08:30 ET | SAB Biotherapeutics, Inc.
SIOUX FALLS, S.D., Aug. 04, 2022 (GLOBE NEWSWIRE) -- SAB Biotherapeutics (NASDAQ: SABS), a clinical-stage biopharmaceutical company with a first of its kind immunotherapy platform that produces...
SuRo Capital Corp. Reports Fourth Quarter and Fiscal Year 2021 Financial Results
March 09, 2022 16:30 ET | SuRo Capital Corp.
Net Asset Value of $11.72 Per Share as of December 31, 2021 Board of Directors Declares $0.11 Per Share Cash Dividend NEW YORK, March 09,...
SuRo Capital Corp. Second Quarter Preliminary Investment Portfolio Update
July 14, 2021 16:30 ET | SuRo Capital Corp.
SAN FRANCISCO, July 14, 2021 (GLOBE NEWSWIRE) -- SuRo Capital Corp. (“SuRo Capital”, the “Company”, “we”, “us”, and “our”) (Nasdaq: SSSS) today provided the following preliminary update on its...
SuRo Capital Corp. Third Quarter 2020 Preliminary Investment Portfolio Update
October 05, 2020 08:44 ET | SuRo Capital Corp
Net Asset Value Anticipated to Be $12.30 to $12.60, Adjusted for $0.40 Per Share in Dividends Conversion Rate Adjustment for Convertible Notes Due to Dividend Announced SAN FRANCISCO, Oct. 05, 2020...